A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.

Ruckdeschel, J C; Finkelstein, D M; Ettinger, D S; Creech, R H; Mason, B A; Joss, R A; Vogl, S

Ruckdeschel, J C; Finkelstein, D M; Ettinger, D S; Creech, R H; Mason, B A; Joss, R A; Vogl, S.

J Clin Oncol ; 4(1): 14-22, 1986 Jan.

Article in En | MEDLINE | ID: mdl-3510278

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Lung Neoplasms/drug therapy; Aged; Cisplatin/administration & dosage; Clinical Trials as Topic; Cyclophosphamide/administration & dosage; Doxorubicin/administration & dosage; Etoposide/administration & dosage; Female; Follow-Up Studies; Humans; Lung Neoplasms/pathology; Male; Methotrexate/administration & dosage; Middle Aged; Mitomycin; Mitomycins/administration & dosage; Neoplasm Metastasis; Procarbazine/administration & dosage; Progesterone/administration & dosage; Random Allocation; Vinblastine/administration & dosage; Vindesine/administration & dosage

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Lung Neoplasms Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 1986 Document type: Article

Search on Google

Add to My VHL

XML

PubMed Links